CYTOKINETICS, INCORPORATED Selling, General and Administrative Expense
CYTOKINETICS, INCORPORATED (CYTK) reported Selling, General and Administrative Expense of $104.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-06
- CYTOKINETICS, INCORPORATED selling, general and administrative expense for the quarter ending 2026-06-30 was $104.40M, a 58.85% increase year-over-year.
- CYTOKINETICS, INCORPORATED selling, general and administrative expense for the quarter ending 2026-03-31 was $104.90M, a 82.84% increase year-over-year.
- CYTOKINETICS, INCORPORATED selling, general and administrative expense for the quarter ending 2025-06-30 was $65.72M.
- CYTOKINETICS, INCORPORATED selling, general and administrative expense for the quarter ending 2025-03-31 was $57.37M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month |
|---|---|---|
| 2026-06-30 | $104.40M 10-Q · filed 2026-08-06 | $209.29M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $104.90M 10-Q · filed 2026-05-05 | |
| 2025-06-30 | $65.72M 10-Q · filed 2026-08-06 | $123.09M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $57.37M 10-Q · filed 2026-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |